Clinical Trials Browser

OTHER × Prostatic Neoplasms × gadopiclenol × Clear all

NCT06226129 2025-10-20

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Phase 4 Recruiting

Prostatic Neoplasms